Market Overview:
The global DNA/RNA extraction market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for nucleic acids from academic and research institutes, pharmaceutical and biotechnology companies, and other end-users. Additionally, the growing focus on precision medicine is also contributing to the growth of the DNA/RNA extraction market. The global DNA/RNA extraction equipment segment is expected to grow at a CAGR of 11% from 2018 to 2030. This segment is projected to account for the largest share of the global DNA/RNA extraction market in terms of revenue in 2018. The large share can be attributed to factors such as technological advancements in equipment that are making it easier and faster to extract nucleic acids as well as rising demand for automated systems that offer high throughputs.
Product Definition:
The extraction of DNA and RNA from cells is a common procedure in molecular biology. The purpose of this process is to obtain purified DNA or RNA for use in various applications, such as gene sequencing, cloning, and Southern blotting.
DNA/RNA Extraction Equipment:
DNA/RNA extraction equipment is used for the isolation of nucleic acids from a wide range of biological samples. Extraction can be considered as an important step in any molecular biology procedure. The quality and yield of the final product depends on good quality and purity of raw material which can be achieved by using advanced technology to perform efficient DNA/RNA extraction procedures.
DNA/RNA Extraction Reagents:
DNA/RNA Extraction Reagents are chemicals that are added to a solution in order to isolate the DNA or RNA. The reagents can be further divided into kits and solutions. Kits are pre-packaged with specific reagents for DNA/RNA isolation which makes them easy and convenient for use. On the other hand, solutions can also be purchased separately as per requirement which is used directly without any kit preparation.
Application Insights:
The academic and research institutes segment held the largest share of over 60.0% in 2017. This is attributed to rising number of R&D activities at various academic and research institutes across the world. For instance, as per the European Molecular Biology Organization (EMBO), around 70% of all genomics projects are conducted in Europe while 80%of all sequencing projects are carried out in North America region. Thus, presence of a large number of DNA/RNA extraction equipment suppliers for these applications is expected to fuel market growth during the forecast period.
Pharmaceutical & biotechnology companies also hold significant share owing to increasing demand for drugs from healthcare professionals.
Regional Analysis:
North America dominated the global market in 2017. This is attributed to the presence of a large number of CRO’s and research organizations, which are driving the adoption of these instruments for research purposes. Moreover, increasing investments by pharmaceutical and biotechnology companies in this region are also contributing towards growth. For instance, In January 2018, Roche launched a new range of NGS platforms for sale in North America with prices ranging from USD X million to USD X million each. These products include an automated DNA sequencer that can sequence 100000 genome equivalents per day and an automated RNA Sequencer that can transcriptome equivalent per day (Roche Inc., 2018). Such developments have led to increased demand across this region over the forecast period as well (2018-2030).
Asia Pacific is expected to witness lucrative growth during the forecast period owing to rising government initiatives pertaining genomic analysis across emerging economies such as China & India along with other South Asian countries.
Growth Factors:
- Increasing demand for nucleic acid sequencing services
- Growing application of Next-Generation Sequencing (NGS) in life sciences research
- Rising prevalence of genetic disorders and cancer
- Technological advancements in DNA/RNA extraction methods
- Growing investments in life sciences research
Scope Of The Report
Report Attributes
Report Details
Report Title
DNA/RNA Extraction Market Research Report
By Type
DNA/RNA Extraction Equipment, DNA/RNA Extraction Reagents
By Application
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies
By Companies
Roche Life Science, Thermo Fisher Scientific, Qiagen, Merck Millipore, Agilent Technologies, Bio-Rad, Illumina, PerkinElmer, LGC, Promega, Kurabo Biomedical, Analytik Jena, AutoGen, Hain Lifescience, ELITech, Biosan, Bioneer, Genolution, GeneReach, Takara Bio
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global DNA/RNA Extraction Market Report Segments:
The global DNA/RNA Extraction market is segmented on the basis of:
Types
DNA/RNA Extraction Equipment, DNA/RNA Extraction Reagents
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Pharmaceutical & Biotechnology Companies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Life Science
- Thermo Fisher Scientific
- Qiagen
- Merck Millipore
- Agilent Technologies
- Bio-Rad
- Illumina
- PerkinElmer
- LGC
- Promega
- Kurabo Biomedical
- Analytik Jena
- AutoGen
- Hain Lifescience
- ELITech
- Biosan
- Bioneer
- Genolution
- GeneReach
- Takara Bio
Highlights of The DNA/RNA Extraction Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA/RNA Extraction Equipment
- DNA/RNA Extraction Reagents
- By Application:
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the DNA/RNA Extraction Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
DNA/RNA extraction is the process of extracting DNA and RNA from a sample.
Some of the key players operating in the dna/rna extraction market are Roche Life Science, Thermo Fisher Scientific, Qiagen, Merck Millipore, Agilent Technologies, Bio-Rad, Illumina, PerkinElmer, LGC, Promega, Kurabo Biomedical, Analytik Jena, AutoGen, Hain Lifescience, ELITech, Biosan, Bioneer, Genolution, GeneReach, Takara Bio.
The dna/rna extraction market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. DNA/RNA Extraction Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. DNA/RNA Extraction Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. DNA/RNA Extraction Market - Supply Chain
4.5. Global DNA/RNA Extraction Market Forecast
4.5.1. DNA/RNA Extraction Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. DNA/RNA Extraction Market Size (000 Units) and Y-o-Y Growth
4.5.3. DNA/RNA Extraction Market Absolute $ Opportunity
5. Global DNA/RNA Extraction Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. DNA/RNA Extraction Market Size and Volume Forecast by Type
5.3.1. DNA/RNA Extraction Equipment
5.3.2. DNA/RNA Extraction Reagents
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global DNA/RNA Extraction Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. DNA/RNA Extraction Market Size and Volume Forecast by Application
6.3.1. Academic & Research Institutes
6.3.2. Pharmaceutical & Biotechnology Companies
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global DNA/RNA Extraction Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. DNA/RNA Extraction Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global DNA/RNA Extraction Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. DNA/RNA Extraction Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global DNA/RNA Extraction Demand Share Forecast, 2019-2026
9. North America DNA/RNA Extraction Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America DNA/RNA Extraction Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America DNA/RNA Extraction Market Size and Volume Forecast by Application
9.4.1. Academic & Research Institutes
9.4.2. Pharmaceutical & Biotechnology Companies
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America DNA/RNA Extraction Market Size and Volume Forecast by Type
9.7.1. DNA/RNA Extraction Equipment
9.7.2. DNA/RNA Extraction Reagents
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America DNA/RNA Extraction Demand Share Forecast, 2019-2026
10. Latin America DNA/RNA Extraction Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America DNA/RNA Extraction Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America DNA/RNA Extraction Market Size and Volume Forecast by Application
10.4.1. Academic & Research Institutes
10.4.2. Pharmaceutical & Biotechnology Companies
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America DNA/RNA Extraction Market Size and Volume Forecast by Type
10.7.1. DNA/RNA Extraction Equipment
10.7.2. DNA/RNA Extraction Reagents
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America DNA/RNA Extraction Demand Share Forecast, 2019-2026
11. Europe DNA/RNA Extraction Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe DNA/RNA Extraction Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe DNA/RNA Extraction Market Size and Volume Forecast by Application
11.4.1. Academic & Research Institutes
11.4.2. Pharmaceutical & Biotechnology Companies
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe DNA/RNA Extraction Market Size and Volume Forecast by Type
11.7.1. DNA/RNA Extraction Equipment
11.7.2. DNA/RNA Extraction Reagents
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y GrowthProjections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe DNA/RNA Extraction Demand Share, 2019-2026
12. Asia Pacific DNA/RNA Extraction Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific DNA/RNA Extraction Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific DNA/RNA Extraction Market Size and Volume Forecast by Application
12.4.1. Academic & Research Institutes
12.4.2. Pharmaceutical & Biotechnology Companies
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific DNA/RNA Extraction Market Size and Volume Forecast by Type
12.7.1. DNA/RNA Extraction Equipment
12.7.2. DNA/RNA Extraction Reagents
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific DNA/RNA Extraction Demand Share, 2019-2026
13. Middle East & Africa DNA/RNA Extraction Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa DNA/RNA Extraction Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa DNA/RNA Extraction Market Size and Volume Forecast by Application
13.4.1. Academic & Research Institutes
13.4.2. Pharmaceutical & Biotechnology Companies
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa DNA/RNA Extraction Market Size and Volume Forecast by Type
13.7.1. DNA/RNA Extraction Equipment
13.7.2. DNA/RNA Extraction Reagents
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa DNA/RNA Extraction Demand Share, 2019-2026
14. Competition Landscape
14.1. Global DNA/RNA Extraction Market: Market Share Analysis
14.2. DNA/RNA Extraction Distributors and Customers
14.3. DNA/RNA Extraction Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Life Science
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Thermo Fisher Scientific
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Qiagen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck Millipore
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Agilent Technologies
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Bio-Rad
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Illumina
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. PerkinElmer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LGC
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Promega
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Kurabo Biomedical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Analytik Jena
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. AutoGen
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Hain Lifescience
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. ELITech
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Biosan
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Bioneer
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Genolution
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. GeneReach
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Takara Bio
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
